Please note this article is for informational purposes only, we do not perform this treatment at our clinics in Sydney, Brisbane or Gold Coast
Mohan, S
This can be due to individual metabolic rates, genetic factors, and how your body processes the medication
In clinical studies , people successfully made the switch by starting at a 5 mg dose of tirzepatide
Piperno A, Rivolta MR, DAlba R, Fargion S, Rovelli F, Ghezzi A, et al
In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers